Herbal medicine hepatotoxicity: A new step with development of specific biomarkers

Journal of Hepatology

Volumn 54, Issue 4, 2011, Pages 599-601

  Larrey, Dominique ^a   Faure, Stéphanie ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; BIOLOGICAL MARKER; ENEMA; GLUTATHIONE; GREEN TEA EXTRACT; HERBACEOUS AGENT; KAVA; PENNYROYAL OIL; PYRROLIZIDINE ALKALOID; UNCLASSIFIED DRUG; VEGETABLE OIL;

AMINOTRANSFERASE BLOOD LEVEL; ATRACTYLIS GUMMIFERA; BIOTRANSFORMATION; CASSIA ANGUSTIFOLIA; CHELIDONIUM; CHILD DEATH; CHINESE MEDICINE; CHRYSANTHEMUM; CHRYSANTHEMUM SEGETUM; COMFREY; CROTALARIA; CYTOSKELETON; EDITORIAL; GERMANDER; GYNURA SEGETUM; HEDEOMA; HEDEOMA PULEGIOIDES; HELIOTROPIUM; HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME; HERBAL MEDICINE; HUMAN; INTOXICATION; LARREA; LARREA TRIDENTATA; LIVER CONGESTION; LIVER FAILURE; LIVER TOXICITY; MEDICINAL PLANT; MENTHA PULEGIUM; NONHUMAN; PIPER METHYSTICUM; PLANT LEAF; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SENECIO; SENNA; TEUCRIUM CHAMAEDRIS; TREATMENT CONTRAINDICATION; VEIN OCCLUSION;

ANIMALS; HUMANS; LIVER; PLANT EXTRACTS; PLANTS, MEDICINAL; PYRROLIZIDINE ALKALOIDS;

EID: 79952699970     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.12.003     Document Type: Editorial

References (20)

1. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47-51. (Pubitemid 127777238)
2. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195-206. (Pubitemid 34496472)
3. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005;43:901-910. (Pubitemid 41414517)
4. Larrey D. Complementary and alternative medicine hepatotoxicity. Permanyer publications. Hepatotoxicity. Ed Raul J Andrade 2007:125-135.
5. Liu LU, Schiano TD. Hepatotoxicity for herbal medicines, vitamins, and natural hepatotoxins. In: Kaplowitz N, Deleve LD, editors. Drug-Induced liver disease. New York, Basel: Marcel Dekker; 2007. p. 733-754.
6. Detkova Z, Lefebvre A, Bastide C, Peladan N, Pageaux GP, Blanc P, et al. Herbal medicine consumption in chronic liver diseases and functional intestinal disorders. Prospective study in 526 outpatients. Gastroenterology 2001;120:A-228.
7. Seeff LB, Curto TM, Szabo G, Everson GT, Bonkosky HL, Dienstag JL, et al. the HALT-C Trial Group. Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology; 47:605-612.
8. Larrey D. Drug-induced liver diseases. J Hepatol 2000;32:77-88. (Pubitemid 30123626)
9. Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J Hepatol 2007;47:514-520. (Pubitemid 47331750)
10. Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products. J Hepatol 2007;47:521-526. (Pubitemid 47331751)
11. www.lakemedelsverket.se.
12. Fu PP, Xia QS, Lin G, Chou MW. Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 2004;36:1-55. (Pubitemid 38387834)
13. Lin G, Wang JY, Li N, Gao H, Ji Y, Zhang F, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 2010;54:666-673.
14. Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharm Ther 2004;23:11-25.
15. Dai N, Yu YC, Ren TH, Wu JG, Jiang Y, Shen LG, et al. Gynura root induces hepatic veno-occlusive disease; a case report and review of the literature. World J Gastroenterol 2007;13:1628-1631. (Pubitemid 46672677)
16. Ridker PM, Mc Dermott V. Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989;7:657-658. (Pubitemid 19078796)
17. Larrey D, Vial T, Pawels A, Castot A, Biour M, David M, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129-132.
18. Lekehal M, Pessayre D, Lereau JM, Moulis C, Fouraste F. Hepatotoxicity of the herbal medicine germander. Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996;24: 212-218.
19. Fau D, Lekehal M, Farrell G, Moreau A, Moulis C, Feldmann G, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997;113:1334-1336.
20. De Berardinis V, Moulis C, Maurice M, Beaune P, Pessayre D, Poupon D, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000;58:542-551.